Comments from the editor-in-chief.
Arceci
Robert J
RJ
D000529:Complementary Therapies; D019337:Hematologic Neoplasms / Q000150:complications / Q000628:therapy; D006801:Humans; D018365:Neoplasm, Residual / Q000628:therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000628:therapy*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000209:etiology / Q000628:therapy; D012067:Religion